TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.
The company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.
The company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.